Speciality Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Education Dialogues
    • Business Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Speciality Medical Dialogues
    • Editorial
    • News
        • Anesthesiology
        • Cancer
        • Cardiac Sciences
        • Critical Care
        • Dentistry
        • Dermatology
        • Diabetes and Endo
        • Diagnostics
        • ENT
        • Featured Research
        • Gastroenterology
        • Geriatrics
        • Medicine
        • Nephrology
        • Neurosciences
        • Nursing
        • Obs and Gynae
        • Ophthalmology
        • Orthopaedics
        • Paediatrics
        • Parmedics
        • Pharmacy
        • Psychiatry
        • Pulmonology
        • Radiology
        • Surgery
        • Urology
    • Practice Guidelines
        • Anesthesiology Guidelines
        • Cancer Guidelines
        • Cardiac Sciences Guidelines
        • Critical Care Guidelines
        • Dentistry Guidelines
        • Dermatology Guidelines
        • Diabetes and Endo Guidelines
        • Diagnostics Guidelines
        • ENT Guidelines
        • Featured Practice Guidelines
        • Gastroenterology Guidelines
        • Geriatrics Guidelines
        • Medicine Guidelines
        • Nephrology Guidelines
        • Neurosciences Guidelines
        • Obs and Gynae Guidelines
        • Ophthalmology Guidelines
        • Orthopaedics Guidelines
        • Paediatrics Guidelines
        • Psychiatry Guidelines
        • Pulmonology Guidelines
        • Radiology Guidelines
        • Surgery Guidelines
        • Urology Guidelines
    LoginRegister
    Speciality Medical Dialogues
    LoginRegister
    • Home
    • Editorial
    • News
      • Anesthesiology
      • Cancer
      • Cardiac Sciences
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endo
      • Diagnostics
      • ENT
      • Featured Research
      • Gastroenterology
      • Geriatrics
      • Medicine
      • Nephrology
      • Neurosciences
      • Nursing
      • Obs and Gynae
      • Ophthalmology
      • Orthopaedics
      • Paediatrics
      • Parmedics
      • Pharmacy
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
    • Practice Guidelines
      • Anesthesiology Guidelines
      • Cancer Guidelines
      • Cardiac Sciences Guidelines
      • Critical Care Guidelines
      • Dentistry Guidelines
      • Dermatology Guidelines
      • Diabetes and Endo Guidelines
      • Diagnostics Guidelines
      • ENT Guidelines
      • Featured Practice Guidelines
      • Gastroenterology Guidelines
      • Geriatrics Guidelines
      • Medicine Guidelines
      • Nephrology Guidelines
      • Neurosciences Guidelines
      • Obs and Gynae Guidelines
      • Ophthalmology Guidelines
      • Orthopaedics Guidelines
      • Paediatrics Guidelines
      • Psychiatry Guidelines
      • Pulmonology Guidelines
      • Radiology Guidelines
      • Surgery Guidelines
      • Urology Guidelines
    • Home
    • Latest News
    • Cholesterol lowering &...

    Cholesterol lowering & dementia drugs could be potential treatment for Parkinson's

    Written by savita thakur thakur Published On 2016-02-16T15:39:59+05:30  |  Updated On 16 Feb 2016 3:39 PM IST
    Cholesterol lowering & dementia drugs could be potential treatment for Parkinsons
    New Delhi: While a clinical trial using cholesterol-lowering treatment Simvastatin in people living with Parkinson's is getting underway in centres across the UK - with the hope that it could become one of a number of effective treatments available to treat Parkinson's; scientists have in another study discovered that a commonly prescribed dementia drug could hold the key to helping prevent debilitating falls for people suffering with Parkinson's.

    The cholesterol-lowering drug trial is part of The Cure Parkinson's Trust's Linked Clinical Trials Programme which is now in its fourth year.

    Each year an international committee comprising many of the most respected Parkinson's experts from around the world analyse a number of pre-selected compounds that show the potential to slow, stop or reverse Parkinson's to bring into clinical trials.

    These compounds already have proven safety records in people and a number of them are already used to treat other conditions.
    This programme has seen diabetes treatments, and treatments for mitochondrial dysfunction, amongst others, move forward into Parkinson's trials in a variety of centres in Europe and the US.

    Another research, published in The Lancet Neurology, shows people with Parkinson's who were given the oral drug rivastigmine were 45 per cent less likely to fall and were considerably steadier when walking, compared to those not taking this medicine.

    Parkinson's UK Research Fellow Dr Emily Henderson and principal researcher on the study, based at the University of Bristol, says, "With the degeneration of dopamine producing nerve cells, people with Parkinson's often have issues with unsteadiness when walking.

    ” Such patients, according to Henderson, also have lower levels of acetylcholine, a chemical which helps us to concentrate - making it extremely difficult to pay attention to walking.

    "We already know that rivastigmine works to treat dementia by preventing the breakdown of acetylcholine; however our study shows for the first time that it can also improve regularity of walking, speed, and balance.

    “This is a real breakthrough in reducing the risk of falls for people with Parkinson's.
    " Parkinson's is a progressive neurological condition that affects movement and speech and at present, there is no cure and little understanding as to why some people develop the condition.

    Worldwide, it is estimated that 10-20 million people are living with the disease and this number is expected to double by 2030.

    Many of these cases are undiagnosed and untreated.

    Cholesterol lowering drugsdementiadementia drugsneurologyParkinson's
    Source : UNI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    savita thakur thakur
    savita thakur thakur
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 12 Oct 2022 7:06 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok